Product Categories
| Country: | China |
|---|---|
| Tel: | 028-81700200 |
| Mobile: | 13308200041 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 3-Oxo-4-aza-5α-αndrost-1-ene-17β-carboxylic Acid Methyl Ester | C20H29NO3 | 103335-41-7 | Details |
| 3-hydroxybenzylhydrazine | C7H10N2O | 637-33-2 | Details |
| N6-Isopentenyladenosine-5'-monophosphate sodium salt | C15H22N5O7P | 20268-93-3 | Details |
| α,α'-Dilaurin | C27H52O5 | 539-93-5 | Details |
| Pseudoerythromycin A Hemiketal | C37H67NO13 | 105900-46-7 | Details |
| Valsartan Benzyl Ester | C31H35N5O3 | 137863-20-8 | Details |
| Sudan Red 7B | C24H21N5 | 6368-72-5 | Details |
| Peruvoside | C30H44O9 | 1182-87-2 | Details |
| Elaidic Acid,Methyl Ester | C19H36O2 | 1937-62-8 | Details |
| 2,3,5-TRIIODOBENZALDEHYDE | C7H3I3O | 477534-99-9 | Details |
| Erythromycin F【Erythromycin Impurity A (EP) 】 | C37H67NO14 | 82230-93-1 | Details |
| Vildagliptin-d3 | C17H25N3O2 | 1217546-82-1 | Details |
| Phenethyl Benzoate | C15H14O2 | 94-47-3 | Details |
| N-Formyl Norfloxacin | C17H18FN3O4 | 70459-04-0 | Details |
| 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid | C21H21N3O4 | 1050477-45-6 | Details |
| 6-Amino-6-deoxy-α-D-glucopyranose | C6H13NO5 | 103119-91-1 | Details |
| N-Demethyl Erythromycin A | C36H65NO13 | 992-62-1 | Details |
| Erythromycin A Enol Ether | C37H65NO12 | 33396-29-1 | Details |
| Methyl 3-Aminocrotonate | C5H9NO2 | 14205-39-1 | Details |
| Dexibuprofen Impurity I/4-Butyl-α-methylbenzeneacetic acid | C13H18O2 | 3585-49-7 | Details |
| 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonxyl]piperazine hydrochloride | C19H25N5O4 | 63590-64-7 | Details |
| 4S-Des-3-chloropyridine Edoxaban | C19H27N5O5S | 767625-11-6 | Details |
| Methyl Cedryl Ketone | C17H26O | 32388-55-9 | Details |
| Acid Red 87 | C20H6Br4Na2O5 | 548-26-5 | Details |
| Fe(III) Octaethylporphine Chloride | C36H44ClFeN4 | 28755-93-3 | Details |
| Acipimox | C6H6N2O3 | 51037-30-0 | Details |
| (2-Fosfomycinyl-1-(hydroxy)propyl)phosphonic Acid | C6H14O8P2 | 1416734-33-2 | Details |
| Zapoterin | 35796-71-5 | Details |
| Deoxystreptamine-kanosaminide | C12H25N3O7 | 20744-51-8 | Details |
| Methyl benzenesulfinate | C7H8O2S | 670-98-4 | Details |
| Sodium acetate trihydrate | C2H9NaO5 | 6131-90-4 | Details |
| 2-Furanyl-1-piperazinylmethanone | C9H12N2O2 | 40172-95-0 | Details |
| Bevacizumab/anti-VEGF | C6638H10160N1720O2108S44 | 216974-75-3 | Details |
| (3S,4S)-Tofacitinib | C16H20N6O | 1092578-47-6 | Details |
| 8－Deoxylactucin | C15H16O4 | 65725-10-2 | Details |
| 2-Deoxystreptamine, Dihydrobromide | C6H15BrN2O3 | 84107-26-6 | Details |
| Valsartan n-Propyl Impurity | C23H27N5O3 | 952652-79-8 | Details |
| Neomenthol | C10H20O | 20747-49-3 | Details |
| N-Ethoxycarbonyl Norfloxacin | C19H22FN3O5 | 105440-01-5 | Details |
| Paucimannose/M3 N-Glycan/Man-3a N-Glycan | C34H58N2O26 | 70858-45-6 | Details |
| Dapagliflozin 3-O-β-D-Glucuronide | C27H33ClO12 | 1351438-75-9 | Details |
| Erythromycin EP Impurity L | C37H65NO14 | 127955-44-6 | Details |
| Humic Acid | C9H9NO6 | 308067-45-0 | Details |
| Estriol 3-glucuronide | C24H32O9 | 2479-91-6 | Details |
| Metomidate Hydrochloride | C13H14N2O2.ClH | 35944-74-2 | Details |
| Sapintoxin D | C30H37NO8 | 80998-07-8 | Details |
| Cycloester Erythromycin Enol Ether | C38H63NO13 | 58781-38-7 | Details |
| Disodium hydrogen citrate 1.5 hydrate/Sodium citrate dibasic sesquihydrate | C6H11NaO8 | 6132-05-4 | Details |
| alpha-Ribazole | C14H18N2O4 | 132-13-8 | Details |
| Dodecylamine | C12H27N | 124-22-1 | Details |
| N-Isopropylacetamide | C5H11NO | 1118-69-0 | Details |
| THEASINENSIN C | C30H26O14 | 89013-69-4 | Details |
| Amitraz Related Compound B | C10H14N2 | 33089-74-6 | Details |
| Fipronil Sulfone | C12H4Cl2F6N4O2S | 120068-36-2 | Details |
| 3-(2-Oxopyrrolidin-1-yl)propanoic Acid | C7H11NO3 | 77191-38-9 | Details |
| 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-Imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic Acid | C19H13ClFN3O2 | 59468-44-9 | Details |
| Erythralosamine | C29H49NO8 | 546-57-6 | Details |
| Pseudo Erythromycin A Enol Ether | C37H65NO12 | 105882-69-7 | Details |
| 5-Methyl-pyrazine-2-carboxylic Acid | C6H6N2O2 | 5521-55-1 | Details |
| 1-PALMITOYL-2-ARACHIDONOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE | C41H74NO8P | 70812-59-8 | Details |
| (4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanone | C23H25N5O5 | 74191-85-8 | Details |
| Erythromycin D | C36H65NO12 | 33442-56-7 | Details |
| Insulin degludec | C274H411N65O81S6 | 844439-96-9 | Details |
| 1-Piperazinecarboxaldehyde, 4-[(2,3,4-triMethoxyphenyl)Methyl]-, hydrochloride | C15H23ClN2O4 | 879646-17-0 | Details |
| 3-(2-Methylphenyl)propionic Acid | C10H12O2 | 22084-89-5 | Details |
| BTT 3033 | C23H20FN5O3S | 1259028-99-3 | Details |
| 19-(tert-Butoxy)-19-oxononadecanoic acid | C23H44O4 | 1643852-37-2 | Details |
| Anhydro Erythromycin A | C37H65NO12 | 23893-13-2 | Details |
| L-Leucine 7-Amido-4-methylcoumarin Hydrochloride | C16H21ClN2O3 | 62480-44-8 | Details |
| Erythromycin EP Impurity C | C37H65NO14 | 41451-91-6 | Details |
| Etiracetam | C8H14N2O2 | 33996-58-6 | Details |
| (R)-Levetiracetam | C8H14N2O2 | 103765-01-1 | Details |
| 4-Amino-2-chloro-6,7-dimethoxyquinazoline | C10H10ClN3O2 | 23680-84-4 | Details |
| Norfloxacin EP Impurity F | C16H18ClN3O3 | 67681-84-9 | Details |
| Desethylene Norfloxacin Hydrochloride | C14H17ClFN3O3 | 1797116-86-9 | Details |
| Glyceryl 1,3-Distearate | C39H76O5 | 504-40-5 | Details |
| Cyclo(alanylleucyl) | C9H16N2O2 | 1803-60-7 | Details |
| 4-Chloro-4’-hydroxybenzophenone | C13H9ClO2 | 42019-78-3 | Details |
| Brilliant Yellow (Technical Grade) | C26H21N4NaO8S2 | 3051-11-4 | Details |
| Hyaluronidase from Bovine Testes | C18H14O7 | 9001-54-1 | Details |
| Cafestol palmitate | C36H58O4 | 81760-46-5 | Details |
| Wilfordinine D | C41H47NO19 | 256937-98-1 | Details |
| Lapatinib | C29H26ClFN4O4S | 231277-92-2 | Details |
| Valsartan Enantiomer/D-Valsartan | C24H29N5O3 | 137862-87-4 | Details |
| 2'-Deoxycytidine HCl | C9H14ClN3O4 | 3992-42-5 | Details |
| 2-DEMETHYLCOLCHICINE | C21H23NO6 | 7336-36-9 | Details |
| 2-Cyano-N-[4-(trifluoromethyl)phenyl]acetamide | C10H7F3N2O | 24522-30-3 | Details |
| 3-O-Methyldopa | C10H13NO4 | 300-48-1 | Details |
| 1-(2-Tetrahydrofuroyl)piperazine Hydrobromide | C9H17BrN2O2 | 63590-62-5 | Details |
| 2-Amino-N-(2-hydroxyethyl)acetamide hydrochloride | C4H11ClN2O2 | 86150-08-5 | Details |
| Erythromycin A N-oxide | C37H67NO14 | 992-65-4 | Details |
| 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1h-benzo[d]imidazole | C11H12BrFN2 | 1231930-33-8 | Details |
| Halofuginone Hydrochloride | C16H18BrCl2N3O3 | 1217623-74-9 | Details |
| O-Desethyl Dapagliflozin | C19H21ClO6 | 864070-37-1 | Details |
| 2,2-Dimethylacetoacetic Acid Ethyl Ester | C8H14O3 | 597-04-6 | Details |
| Vildagliptin Cyclo Imidamide | C17H25N3O2 | 1789703-37-2 | Details |
| 7,8-Difluorodibenzo[b,e]thiepin-11(6H)-one | C14H8F2OS | 2136287-66-4 | Details |
| Naphthalene-1-sulfonic Acid (Technical Grade) | C10H8O3S | 85-47-2 | Details |
| 3-Methoxy-p-tyramine Hydrochloride | C9H13NO2.ClH | 1477-68-5 | Details |
| Product Total： Product Page： | ||||
| 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 | ||||